Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Generate Biomedicines, Inc. (GENB)

NASDAQ

$16.14

$+0.23

(+1.44%)

Pre-Market

Generate Biomedicines, Inc. (GENB) Live Price Chart

Last updated: ⁦2026-09-16 09:06:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Generate Biomedicines, Inc. (GENB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $16.14, with a market capitalisation of $2.05B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $11.00 to $22.67. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.05B
Open	$15.91
Day's High	$22.67
Day's Low	$11.00
Previous Close	$16.19
Volume	240.00
Average Volume	1.04M
P/E Ratio	--
52-Week High	$22.67
52-Week Low	$11.00
Dividend Yield	--
Earnings Date	--

Generate Biomedicines, Inc. (GENB) Pre-Market Stock Price

Generate Biomedicines, Inc. (GENB) is trading at $16.14 in pre-market trading as of 2026-09-16 08:27:00, down 0.34% ($0.05) from the previous close of $16.19

Pre-market trading shows how investors are pricing GENB before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Generate Biomedicines, Inc. (GENB) 7-Day Stock Price Change

Over the past seven days, Generate Biomedicines, Inc. (GENB) moved from $16.39 to $16.14, representing a decline of 1.56% ($0.25).

The stock traded between $15.03 and $16.62 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 1.02 million shares, down versus the previous seven-day period, indicating lower trading activity.

GENB 52-Week Price Position

Position in Range: 44.0%

52W Low$11.00

52W High$22.67

GENB is currently trading at $16.14, placing it 44.0% of the way from its 52-week low of $11.00 to its 52-week high of $22.67. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Generate Biomedicines, Inc. (GENB)?

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Generate Biomedicines, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Exchange	NASDAQ
Company Website	https://www.generatebiomedicines.com

How to Buy Generate Biomedicines, Inc. (GENB) Stock on MEXC

Eligible investors can buy real shares of Generate Biomedicines, Inc. (GENB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GENB and Place Your Order

Open the RealStocks trading page and search for GENB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Generate Biomedicines, Inc. (GENB) stock price today?

Generate Biomedicines, Inc. (GENB) is currently trading at $ 16.14, down 0.34% ($0.05) from the previous close of $ 16.19. Intraday prices update in real time during regular trading hours.

2.Is GENB stock going up or down today?

As of 2026-09-16 08:27:00, GENB is trading at $ 16.14, down 0.34% ($0.05) from its previous close of $ 16.19. The stock has traded between $ 11.00 and $ 22.67 during today’s regular session. Past price movements do not guarantee future results.

3.What is GENB pre-market price?

As of 2026-09-16 08:27:00, GENB is trading at $ 16.14 in pre-market trading, down 0.34% ($0.05) from the previous close of $ 16.19. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GENB after-hours price?

As of 2026-09-16 08:27:00, GENB is trading at $ 15.90 in after-hours trading, down 1.79% ($0.29) from the regular-session close of $ 16.19. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GENB stock trading now?

GENB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GENB sit relative to its 52-week high and low?

Over the past 52 weeks, GENB has traded between a low of $ 11.00 and a high of $ 22.67. At $ 16.14, the stock is positioned 44.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Generate Biomedicines, Inc. in?

Generate Biomedicines, Inc. (GENB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Generate Biomedicines, Inc.'s market capitalisation and where is it listed?

Generate Biomedicines, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 2.05B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GENB valued in terms of P/E ratio and EPS?

GENB trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Generate Biomedicines, Inc. pay a dividend?

Generate Biomedicines, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.